Linagliptin and Metformin Extended-Release Tablets and Ranibizumab Intraocular
Determining the interaction of Linagliptin and Metformin Extended-Release Tablets and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and metformin, Linagliptin and Metformin
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Linagliptin and Metformin Extended-Release Tablets-Ranibizumab ophthalmic
- Linagliptin and Metformin Extended-Release Tablets-Ranitidine
- Linagliptin and Metformin Extended-Release Tablets-Ranitidine Capsule
- Linagliptin and Metformin Extended-Release Tablets-Ranitidine Hydrochloride
- Linagliptin and Metformin Extended-Release Tablets-Ranitidine Injection
- Linagliptin and Metformin Extended-Release Tablets-Ranitidine Suspension
- Ranibizumab Intraocular-Linagliptin and Metformin Tablets
- Ranibizumab Intraocular-Lincocin
- Ranibizumab Intraocular-Lincomycin
- Ranibizumab Intraocular-Lincomycin Hydrochloride
- Ranibizumab Intraocular-Lincomycin Injection
- Ranibizumab Intraocular-Lincomycin Oral, Injection